ECP 2023 Final Programme

E-Posters 153 ECP 2023 Dublin E-PS-15 008 Unravelling leukemic landscapes: cerebro- spinal fluid-derived next generation sequencing analysis provides comprehen- sive diagnostic, therapeutic and prognostic perceptions Ozgur Can Eren, Turkey I. Kulac, T. Akan, O. Dogan, C. Aydin Mericoz 009 Robust validation and implementation of the C2i genomics whole-genome sequenc- ing minimal residual disease assay for ultrasensitive ctDNA detection in liquid biopsy Ariel Erental, Israel T. Katz-Ezov, R. Tzabari, R. Campbell, U. Alon, D. Afterman, B. Oklander, A. Zviran, D. Hershkovitz 010 Implementation of the SOPHiA DDM™ homologous recombination deficiency (HRD) solution to detect HRD in ovarian cancer tumours Ariel Erental, Israel A. Kaplan, C. Wizeman, R. Tzabari, L. Ifat, A. Mager, Y. Inbaram, D. Hershkovitz 011 Long non-coding RNA NEAT1 cannot be used as a diagnostic and prognostic biomarker in patients with locally advanced rectal cancer Katarina Eric, Serbia J. Rosic, M. Miladinov, S. Dragicevic, G. Barisic, V. Markovic, K. Zeljic 012 Stability of testing of microsatellite instability Jennifer Fairley, United Kingdom S. Deans 013 Epigenetic analysis of surrogate markers in consensus molecular subtypes of colon cancer David Guerrero, Spain I. Fernández De Los Reyes, I. Monreal- Santesteban, L. Alonso, B. Fernández- Marlasca, P. Azcue, J. Suarez, M. Gómez- Dorronsoro 014 Usefulness of an extense Next Generation Sequencing panel in endometrial cancer David Guerrero, Spain T. Zudaire, I. Fernández De Los Reyes, Y. Laplaza, P. Fernández, M. Caballero, B. Fernández-Marlasca, E. Gochi, M. Gómez, J. Muruzabal, R. Guarch 015 Comparison of diagnostic coverage of RET fusion partners by various RNA-based assays Manu Gupta, United Kingdom A. Mota, I. Simon, J. Cazier 016 Feasibility and impact of retrospective testing for RET fusions and other actionable biomarkers not previously tested in non-small cell lung cancer cases: an experience from England Manu Gupta, United Kingdom J. Bradbury, H. Sanna, S. Forrest, S. Taylor, C. Felix, F. Carter, C. Escriu, S. Brown, D. Bury, J. Gosney, M. Powari, M. Evans 017 Implementation of a multidisciplinary molecular tumourboard (MTB) Lena Haeberle, Germany S. Labuhn, M. Schlensog, W. Goering, K. Horny, S. Redler, I. Esposito 018 Squamous cell carcinoma of the lung with microsatellite instability in a patient with Lynch syndrome: a case report Emna Haddad, France B. Bottet, P. Thiebaut, S. Morin, H. Dreyfus, E. Vanier, C. Vincent, H. Sobol, F. Marguet, J. Baste, F. Guisier, J. Sabourin, N. Piton 019 Whole-exome sequencing of brain metastases and paired primary tumours of small cell lung carcinoma – preliminary results Katharina Heß, Germany F. Kellers, A. Kuenstner, N. Reimer, S. Fliedner, H. Busch, L. Bastian, C. Röcken, B. Konukiewitz